Citadel Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.08M Sell
43,800
-2,500
-5% -$221K ﹤0.01% 4680
2025
Q4
$3.72M Sell
46,300
-43,300
-48% -$3.63M ﹤0.01% 4787
2025
Q3
$8.75M Sell
89,600
-102,200
-53% -$8.23M ﹤0.01% 3470
2025
Q2
$13.4M Sell
191,800
-96,800
-34% -$5.52M ﹤0.01% 2652
2025
Q1
$14.3M Buy
288,600
+104,600
+57% +$6.61M ﹤0.01% 2412
2024
Q4
$12.9M Buy
184,000
+98,000
+114% +$8.14M ﹤0.01% 2657
2024
Q3
$9.02M Sell
86,000
-20,700
-19% -$2.42M ﹤0.01% 3077
2024
Q2
$15.2M Sell
106,700
-60,800
-36% -$7.01M ﹤0.01% 2297
2024
Q1
$18.7M Buy
167,500
+3,500
+2% +$417K ﹤0.01% 2142
2023
Q4
$21.3M Buy
164,000
+75,200
+85% +$10.4M ﹤0.01% 1951
2023
Q3
$14.5M Buy
88,800
+41,400
+87% +$7.28M ﹤0.01% 2231
2023
Q2
$8.69M Buy
47,400
+7,400
+19% +$1.07M ﹤0.01% 2866
2023
Q1
$5.33M Buy
40,000
+15,600
+64% +$1.83M ﹤0.01% 3703
2022
Q4
$1.94M Sell
24,400
-59,500
-71% -$4.19M ﹤0.01% 5548
2022
Q3
$5.08M Buy
83,900
+33,800
+67% +$2.18M ﹤0.01% 3836
2022
Q2
$2.75M Sell
50,100
-7,800
-13% -$452K ﹤0.01% 4924
2022
Q1
$4.37M Sell
57,900
-39,100
-40% -$2.67M ﹤0.01% 4440
2021
Q4
$7.23M Buy
97,000
+56,400
+139% +$3.34M ﹤0.01% 3653
2021
Q3
$1.91M Buy
40,600
+23,000
+131% +$1M ﹤0.01% 6477
2021
Q2
$711K Buy
17,600
+5,300
+43% +$220K ﹤0.01% 9211
2021
Q1
$505K Buy
12,300
+4,700
+62% +$175K ﹤0.01% 9656
2020
Q4
$221K Sell
7,600
-16,900
-69% -$437K ﹤0.01% 9589
2020
Q3
$539K Buy
24,500
+9,300
+61% +$237K ﹤0.01% 7164
2020
Q2
$423K Buy
15,200
+3,100
+26% +$75.6K ﹤0.01% 7349
2020
Q1
$222K Buy
+12,100
New +$281K ﹤0.01% 7836
2018
Q4
Sell
-13,900
Closed -$273K 9008
2018
Q3
$273K Buy
+13,900
New +$286K ﹤0.01% 7727
2018
Q1
Sell
-25,400
Closed -$729K 8205
2017
Q4
$729K Buy
+25,400
New +$799K ﹤0.01% 5102
2017
Q3
Sell
-10,100
Closed -$212K 7461
2017
Q2
$212K Buy
+10,100
New +$213K ﹤0.01% 6481
2015
Q4
Sell
-700
Closed -$7K 8662
2015
Q3
$7K Sell
700
-200
-22% -$2.44K ﹤0.01% 8562
2015
Q2
$11K Buy
+900
New +$10.4K ﹤0.01% 8375
2014
Q2
Sell
-350
Closed -$3K 7923
2014
Q1
$3K Sell
350
-450
-56% -$4.14K ﹤0.01% 7695
2013
Q4
$8K Buy
+800
New +$7.26K ﹤0.01% 6748

Other funds holding ACLS

Citadel Advisors's ACLS Position: Q1 2026 in Review

Citadel Advisors reduced its Axcelis (ACLS) stake by 97% in Q1 2026, selling an estimated $15.2M and leaving 4,505 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #9730.

Citadel Advisors first reported a position in ACLS in Q2 2013 and has held it in 43 quarters since. The position peaked at $22.9M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Citadel Advisors held 4,505 shares of Axcelis worth $419K as of Q1 2026.
  • Citadel Advisors sold 171,542 Axcelis shares in Q1 2026, an estimated $15.2M.
  • Axcelis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9730 holding.
  • Citadel Advisors first reported a position in Axcelis in Q2 2013 and has held it in 43 quarters since.
  • Citadel Advisors's Axcelis position peaked at $22.9M in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.